ABBVIE INC (ABBV)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for ABBV
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| ABBV | Chief Executive Officer, Health Care | 54 | ["30+ year career at Procter & Gamble", "President, Feminine Care (2019 - 2022)", "President, Global Feminine Care (2018 - 2019)", "Vice President - Feminine Care, North America and Brand Franchise Leader, Tampax (2016 - 2018)", "Experience in marketing and commercial strategy", "Corporate strategy and leadership", "Consumer behavior and business development expertise", "Oversight of health care research and development, manufacturing, quality, and supply, and regulatory compliance"] | ["Nominations & Governance"] | 2026 |
Biography sourced from the proxy statement filing.
Ms. Davis currently serves as Chief Executive Officer, Health Care at Procter & Gamble (P&G), a position she has held since 2022. Ms. Davis previously served at P&G as President, Feminine Care (2019 - 2022), President, Global Feminine Care (2018 - 2019), and Vice President - Feminine Care, North America and Brand Franchise Leader, Tampax (2016 - 2018), in addition to various commercial roles with increasing responsibility in her 30+ year career at P&G. Ms. Davis plans to retire from P&G in June 2026. Key Contributions to the Board: As a result of her extensive tenure at P&G, Ms. Davis brings to the Board marketing and other commercial strategy and execution experience, as well as corporate strategy and leadership, consumer behavior, and business development expertise. She also has substantial experience overseeing P&G s health care research and development, manufacturing, quality, and supply, and regulatory compliance.